Medpace Holdings, Inc. (MEDP) EPS Basic: 15.92
Is Medpace Holdings, Inc.’s EPS basic high or low?
Medpace Holdings, Inc.'s EPS basic of 15.92 is 75% above its 5-year average of 9.10, near the high end of its 5-year range (4.07–15.92).
10.94% above its 12-month average of 14.35.
MEDP EPS Basic Chart
MEDP Average EPS Basic Chart
MEDP Current vs Average EPS Basic Chart
MEDP EPS Basic Metrics
EPS BASIC
15.92
EPS BASIC AVG TTM
14.35
EPS BASIC AVG 3Y
11.37
EPS BASIC AVG 5Y
9.10
EPS BASIC AVG 10Y
5.50
EPS BASIC AVG 15Y
N/A
EPS BASIC AVG 20Y
N/A
CURRENT VS TTM AVG
+10.94%
CURRENT VS 3Y AVG
+40.05%
CURRENT VS 5Y AVG
+74.95%
CURRENT VS 10Y AVG
+189.26%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Medpace Holdings, Inc. EPS Basic Formula & Definition
EPS Basic is earnings per common share before the effect of potentially dilutive securities. It shows how much profit is attributable to each current common share.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medpace Holdings, Inc. EPS Basic FAQ
- What is the EPS basic for Medpace Holdings, Inc. (MEDP)?
- The EPS basic for MEDP stock is 15.92.
- Is Medpace Holdings, Inc.'s EPS basic high or low?
- Medpace Holdings, Inc.'s EPS basic of 15.92 is 75% above its 5-year average of 9.10, near the high end of its 5-year range (4.07–15.92).
- What is the TTM average EPS basic for Medpace Holdings, Inc. (MEDP)?
- The TTM average EPS basic for MEDP stock is 14.35.
- What is the 3Y average EPS basic for Medpace Holdings, Inc. (MEDP)?
- The 3Y average EPS basic for MEDP stock is 11.37.
- What is the 5Y average EPS basic for Medpace Holdings, Inc. (MEDP)?
- The 5Y average EPS basic for MEDP stock is 9.10.
- What is the 10Y average EPS basic for Medpace Holdings, Inc. (MEDP)?
- The 10Y average EPS basic for MEDP stock is 5.50.
Medpace Holdings, Inc. EPS Basic History
| DATE | EPS BASIC |
|---|---|
| 2025-12-31 | 15.64 |
| 2024-12-31 | 13.06 |
| 2023-12-31 | 9.20 |
| 2022-12-31 | 7.57 |
| 2021-12-31 | 5.06 |
| 2020-12-31 | 4.07 |
| 2019-12-31 | 2.79 |
| 2018-12-31 | 2.05 |
| 2017-12-31 | 1.00 |
| 2016-12-31 | 0.38 |
| 2015-12-31 | -0.28 |
| 2014-12-31 | -0.53 |
| 2013-12-31 | 1.33 |
Related Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle